Cite

HARVARD Citation

    Blommestein, H. et al. (n.d.). Cost‐effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population‐based study. European journal of haematology. pp. 398-406. [Online]. 
  
Back to record